Insights into Chinese prostate cancer with RNA-seq
- PMID: 22453238
- PMCID: PMC3343652
- DOI: 10.1038/cr.2012.50
Insights into Chinese prostate cancer with RNA-seq
Figures
Comment on
-
RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings.Cell Res. 2012 May;22(5):806-21. doi: 10.1038/cr.2012.30. Epub 2012 Feb 21. Cell Res. 2012. PMID: 22349460 Free PMC article.
References
-
- Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Shao Q, Ouyang J, Fan Y, et al. Prostate cancer in the senior men from rural areas in east district of China: Contemporary management and 5-year outcomes at multi-institutional collaboration. Cancer Lett. 2012;315:170–177. - PubMed
-
- Squire JA, Park PC, Yoshimoto M, et al. Prostate cancer as a model system for genetic diversity in tumors. Adv Cancer Res. 2011;112:183–216. - PubMed
-
- Tomlins SA, Rhodes DR, Perner S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644–648. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
